As of 2026-09-12, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (74.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -7482378885.0%.
The range of the Relative Valuation is (41.64) - (87.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 21.5x | 18.9x |
| Forward P/E multiples | 9.3x - 20.3x | 15.6x |
| Fair Price | (41.64) - (87.97) | (74.82) |
| Upside | -4164106554.3% - -8796674984.6% | -7482378885.0% |
| Date | P/E |
| 2026-08-27 | -0.00 |
| 2026-08-07 | -0.00 |
| 2026-07-30 | -0.00 |
| 2026-07-08 | -0.00 |
| 2026-06-15 | -0.00 |